Cure My Disease

Don't miss your cure!

 Log in / Sign up

20-minute web tool could ease OCD caregiver burden

NCT ID NCT07158801

Recruiting now Symptom relief Sponsor: Boston University Charles River Campus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 20-25 minute online program called Project EMPOWER-OCD for caregivers of people with OCD. The program teaches caregivers how to reduce accommodating behaviors that can accidentally make OCD worse. Researchers want to see if it lowers caregiver stress and improves OCD symptoms in the person they care for. The trial enrolls 110 English-speaking caregivers who live with and care for someone with OCD.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Project EMPOWER-OCD (a web-based single-session behavioral intervention)
What this could lead to
If it works, this could offer a quick, low-cost way to ease caregiver distress and reduce behaviors that may worsen OCD symptoms.
What could go wrong
This is an early-stage trial with only 110 participants, so results may not apply to all caregivers. The intervention is brief and may not be enough for severe cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE - COMPULSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obsessive-compulsive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSESSIVE - COMPULSIVE DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Boston University

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.